Business Context and Reporting Period
This Form 8-K was filed by Neuralstem, Inc. (not Palisade Bio, Inc.) on February 20, 2013. The report covers a specific corporate event occurring on the same date regarding intellectual property licensing.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on a non-financial operational event.
Material Changes
On February 20, 2013, Neuralstem, Inc. granted licenses to Cedars-Sinai Medical Center in Los Angeles, California. The licensed intellectual property includes:
- Spinal Cord Delivery Platform
- Floating Cannula
- Method for delivering therapeutic agents to the spinal cord
Guidance, Outlook, and Risks
The filing does not contain financial guidance, management commentary on future performance, or specific risk factors beyond the disclosure of the licensing agreement. A press release detailing the event is attached as Exhibit 99.01.
Investor Verification Checklist
- Verify the terms and financial consideration of the license agreement with Cedars-Sinai Medical Center in the attached press release (Exhibit 99.01).
- Confirm the scope of the "Spinal Cord Delivery Platform" and "Floating Cannula" intellectual property rights transferred.
- Review subsequent filings for any financial impact resulting from this licensing arrangement.